A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors.

Christophe MassardP A CassierA AzaroB AndersonE YuenD YuG OakleyK A BenhadjiS Pant

Published in: Cancer chemotherapy and pharmacology (2022)

gov Identification Number: NCT02784795.

Keyphrases